This article is the result of the North American Neuroendocrine Tumor Society consensus
conference on the medical management of pancreatic neuroendocrine tumors from July 19 …

According to the 2019 WHO pathology grading system, high-grade gastroenteropancreatic
neuroendocrine neoplasms (GEP-NENs) can be divided into well differentiated …

High-grade neuroendocrine neoplasms are a rare disease entity and account for
approximately 10% of all neuroendocrine neoplasms. Because of their rarity, there is an …

Background: Gastroenteropancreatic (GEP) neuroendocrine neoplasms with Ki-67> 20%
were subdivided in the most recent 2019 World Health Organization histopathological …

Introduction Recent classification of neuroendocrine neoplasms has defined well‐
differentiated high‐grade neuroendocrine tumors (NET G3) as a distinct entity from poorly …

There is no standardized treatment for grade 3 neuroendocrine tumors (G3 NETs). We
aimed to describe the treatments received in patients with advanced G3 NETs and compare …

Small intestinal neuroendocrine tumours (Si-NET) are often studied as a uniform group.
Proliferation index Ki-67 influences prognosis and determines tumour grade. We …

Grade 3 neuroendocrine neoplasms (NEN G3) are high-grade (Ki-67 index> 20%)
neuroendocrine malignancies that comprise both rapidly proliferating, well-differentiated …

The classification and management of neuroendocrine neoplasms (NENs) arising in the
tubular gastrointestinal (GI) tract and pancreas have significantly evolved over the last …

Objectives We evaluated a population-based cohort of metastatic well-differentiated grade 3
gastroenteropancreatic neuroendocrine tumors (G3 NETs) to describe their characteristics …